Deferred Tax Assets, Valuation Allowance of Verrica Pharmaceuticals Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Verrica Pharmaceuticals Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Verrica Pharmaceuticals Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $73,738,000, a 4% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Verrica Pharmaceuticals Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $73,738,000 +$2,851,000 +4% 31 Dec 2025 10-K 11 Mar 2026 2025 FY
Q4 2024 $70,887,000 +$17,203,000 +32% 31 Dec 2024 10-K 11 Mar 2026 2025 FY
Q4 2023 $53,684,000 +$13,952,000 +35% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q4 2022 $39,732,000 +$1,318,000 +3.4% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $38,414,000 +$9,551,000 +33% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q4 2020 $28,863,000 +$13,028,000 +82% 31 Dec 2020 10-K 02 Mar 2022 2021 FY
Q4 2019 $15,835,000 +$8,452,000 +114% 31 Dec 2019 10-K 17 Mar 2021 2020 FY
Q4 2018 $7,383,000 +$5,410,000 +274% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q4 2017 $1,973,000 31 Dec 2017 10-K 07 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.